ALDH2 and lung cancer: Downregulation of ALDH2 has been demonstrated to improve the efficacy of anthracyclines in renal cell carcinoma via von Hippel-Lindau (VHL) deficiency 13 and to sensitize lung cancers to paclitaxel by reducing cancer stemness 14.